Uterine cancer, also known as endometrial cancer, represents a significant segment of gynecologic malignancies worldwide. Innovations in pharmaceutical treatments have transformed the therapeutic landscape, offering new hope for enhanced patient outcomes. The rapid development of uterine cancer drugs, ranging from hormone therapies to immunotherapies and targeted agents, reflects ongo... https://www.coherentmarketinsights.com/market-insight/uterine-cancer-drugs-market-1745